# Suramin in Treating Patients With Recurrent Bladder Cancer

> **NCT00006476** · PHASE1 · COMPLETED · sponsor: **Cancer Research UK** · enrollment: 15 (estimated)

## Conditions studied

- Bladder Cancer

## Interventions

- **DRUG:** suramin
- **PROCEDURE:** conventional surgery

## Key facts

- **NCT ID:** NCT00006476
- **Lead sponsor:** Cancer Research UK
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-10
- **Primary completion:** —
- **Final completion:** 2007-10
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2013-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006476

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006476, "Suramin in Treating Patients With Recurrent Bladder Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00006476. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*